HTRS2023.P2.22 Evaluating the effectiveness and safety of damoctocog alfa pegol prophylaxis in hemophilia A patients with a history of factor VIII inhibitors from the real-world HEM-POWR study

Autor: Reding, Mark T., Román, María Teresa Álvarez, Sanabria, Martin, Castaman, Giancarlo, Janbain, Maissa, Matsushita, Tadashi, Meijer, Karina, Schmidt, Kathrin, Oldenburg, Johannes
Zdroj: In Research and Practice in Thrombosis and Haemostasis August 2023 7 Supplement 1
Databáze: ScienceDirect
Externí odkaz: